Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Parkinson's disease and dementia: a longitudinal study (DEMPARK).

Balzer-Geldsetzer M, Costa AS, Kronenbürger M, Schulz JB, Röske S, Spottke A, Wüllner U, Klockgether T, Storch A, Schneider C, Riedel O, Wittchen HU, Seifried C, Hilker R, Schmidt N, Witt K, Deuschl G, Mollenhauer B, Trenkwalder C, Liepelt-Scarfone I, Gräber-Sultan S, Berg D, Gasser T, Kalbe E, Bodden M, Oertel WH, Dodel R.

Neuroepidemiology. 2011;37(3-4):168-76. doi: 10.1159/000331490. Epub 2011 Nov 4.

PMID:
22067139
2.

Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.

Galtier I, Nieto A, Lorenzo JN, Barroso J.

J Clin Exp Neuropsychol. 2016;38(1):40-50. doi: 10.1080/13803395.2015.1087465. Epub 2015 Nov 25.

PMID:
26602176
3.

Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.

Yoon JH, Kim M, Moon SY, Yong SW, Hong JM.

J Neurol Sci. 2015 Aug 15;355(1-2):174-9. doi: 10.1016/j.jns.2015.06.013. Epub 2015 Jun 10.

PMID:
26076880
4.

PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies.

Gomperts SN, Marquie M, Locascio JJ, Bayer S, Johnson KA, Growdon JH.

Neurodegener Dis. 2016;16(1-2):118-24. doi: 10.1159/000441421. Epub 2015 Dec 8.

5.

Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.

Hobson P, Meara J.

Int J Geriatr Psychiatry. 2015 Oct;30(10):1048-55. doi: 10.1002/gps.4261. Epub 2015 Feb 11.

PMID:
25676160
6.

α-synuclein genetic variability: A biomarker for dementia in Parkinson disease.

Guella I, Evans DM, Szu-Tu C, Nosova E, Bortnick SF; SNCA Cognition Study Group, Goldman JG, Dalrymple-Alford JC, Geurtsen GJ, Litvan I, Ross OA, Middleton LT, Parkkinen L, Farrer MJ.

Ann Neurol. 2016 Jun;79(6):991-9. doi: 10.1002/ana.24664. Epub 2016 May 5.

7.

Predictors of cognitive impairment in an early stage Parkinson's disease cohort.

Hu MT, Szewczyk-Królikowski K, Tomlinson P, Nithi K, Rolinski M, Murray C, Talbot K, Ebmeier KP, Mackay CE, Ben-Shlomo Y.

Mov Disord. 2014 Mar;29(3):351-9. doi: 10.1002/mds.25748. Epub 2014 Jan 6.

8.

The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.

Sunwoo MK, Jeon S, Ham JH, Hong JY, Lee JE, Lee JM, Sohn YH, Lee PH.

Eur J Neurol. 2014 Jun;21(6):922-e50. doi: 10.1111/ene.12412. Epub 2014 Mar 24.

PMID:
24661277
9.

Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia.

Gomperts SN, Locascio JJ, Rentz D, Santarlasci A, Marquie M, Johnson KA, Growdon JH.

Neurology. 2013 Jan 1;80(1):85-91. doi: 10.1212/WNL.0b013e31827b1a07. Epub 2012 Dec 12.

10.

Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.

Lee JE, Cho KH, Song SK, Kim HJ, Lee HS, Sohn YH, Lee PH.

J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):7-16. doi: 10.1136/jnnp-2013-305062. Epub 2013 Jul 4.

PMID:
23828835
11.

Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.

Kalbe E, Rehberg SP, Heber I, Kronenbuerger M, Schulz JB, Storch A, Linse K, Schneider C, Gräber S, Liepelt-Scarfone I, Berg D, Dams J, Balzer-Geldsetzer M, Hilker R, Oberschmidt C, Witt K, Schmidt N, Mollenhauer B, Trenkwalder C, Spottke A, Roeske S, Wittchen HU, Riedel O, Dodel R.

J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1099-105. doi: 10.1136/jnnp-2016-313838. Epub 2016 Jul 8.

PMID:
27401782
12.

Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.

Pedersen KF, Larsen JP, Tysnes OB, Alves G.

JAMA Neurol. 2013 May;70(5):580-6. doi: 10.1001/jamaneurol.2013.2110.

PMID:
23529397
13.

Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.

Pedersen KF, Larsen JP, Tysnes OB, Alves G.

Neurology. 2017 Feb 21;88(8):767-774. doi: 10.1212/WNL.0000000000003634. Epub 2017 Jan 20.

PMID:
28108638
14.

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.

Rolinski M, Fox C, Maidment I, McShane R.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD006504. doi: 10.1002/14651858.CD006504.pub2. Review.

PMID:
22419314
15.

Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease.

Pagonabarraga J, Gómez-Ansón B, Rotger R, Llebaria G, García-Sánchez C, Pascual-Sedano B, Gironell A, Delfino M, Ruscalleda J, Kulisevsky J.

Dement Geriatr Cogn Disord. 2012;34(5-6):312-8. doi: 10.1159/000345537. Epub 2012 Dec 3.

PMID:
23208306
16.

Longitudinal study of normal cognition in Parkinson disease.

Pigott K, Rick J, Xie SX, Hurtig H, Chen-Plotkin A, Duda JE, Morley JF, Chahine LM, Dahodwala N, Akhtar RS, Siderowf A, Trojanowski JQ, Weintraub D.

Neurology. 2015 Oct 13;85(15):1276-82. doi: 10.1212/WNL.0000000000002001. Epub 2015 Sep 11.

17.

Dementia and cognitive impairment in patients with Parkinson's disease from India: a 7-year prospective study.

Sanyal J, Banerjee TK, Rao VR.

Am J Alzheimers Dis Other Demen. 2014 Nov;29(7):630-6. doi: 10.1177/1533317514531442. Epub 2014 Apr 24.

PMID:
24771763
18.

Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).

Arevalo-Rodriguez I, Smailagic N, Roqué I Figuls M, Ciapponi A, Sanchez-Perez E, Giannakou A, Pedraza OL, Bonfill Cosp X, Cullum S.

Cochrane Database Syst Rev. 2015 Mar 5;(3):CD010783. doi: 10.1002/14651858.CD010783.pub2. Review.

PMID:
25740785
19.

Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia.

Borroni B, Premi E, Formenti A, Turrone R, Alberici A, Cottini E, Rizzetti C, Gasparotti R, Padovani A.

Parkinsonism Relat Disord. 2015 Sep;21(9):1049-55. doi: 10.1016/j.parkreldis.2015.06.013. Epub 2015 Jun 16.

PMID:
26109553
20.

The mild cognitive impairment stage of dementia with Lewy bodies and Parkinson disease: a comparison of cognitive profiles.

Yoon JH, Lee JE, Yong SW, Moon SY, Lee PH.

Alzheimer Dis Assoc Disord. 2014 Apr-Jun;28(2):151-5. doi: 10.1097/WAD.0000000000000007.

PMID:
24126215

Supplemental Content

Support Center